PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
01-Jun-2022 Novavax Initiates Phase 3 Trial of its COVID-19 Omicron Strain Vaccine as a Booster Novavax
01-Jun-2022 Global Biosimilars and Follow-on Biologics R&D Market is projected to reach a market value of US$ 2,22,576.5 Million in 2031: Visiongain Research Inc Visiongain
01-Jun-2022 BIOCAPTIVA announces oversubscribed £2.1 million additional seed financing to complete first in human trial with the BioCaptis BIOCAPTIVA
31-May-2022 Update on Cialis® Rx-to-OTC Switch Actual Use Trial Sanofi
31-May-2022 US FDA accepts New Drug Application filed by Avillion for AstraZeneca’s PT027 for the as-needed treatment or prevention of symptoms in asthma patients AstraZeneca
30-May-2022 Global Single Cell Analysis Market is Projected to Grow at a CAGR of 15.1% By 2032 Visiongain
27-May-2022 First patients dosed in IRIS Phase III trial evaluating Saphnelo in lupus nephritis PUBLISHED27 May 2022 AstraZeneca
27-May-2022 Oxford BioTherapeutics to Present Initial Positive Data from Phase I Trial at ASCO 2022 Oxford BioTherapeutics
27-May-2022 NovalGen announces compelling data from the Phase 1/2 Study of NVG-111 at the ASCO Annual Meeting NovalGen
27-May-2022 Transgene to Present Updated Positive Preliminary Data from the Phase I Clinical Trials with TG4050 (myvac® platform) at ASCO 2022 Transgene
27-May-2022 4D pharma presents trial in progress poster on the Phase II Study of MRx0518 in combination with BAVENCIO(R) in patients with unresectable locally advanced or metastatic urothelial carcinoma at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting 4D pharma plc
27-May-2022 Elevar Therapeutics Announces Rivoceranib Demonstrated Clinical Effectiveness in Patients with Progressive Recurrent or Metastatic Adenoid Cystic Carcinoma in a Phase 2 Trial Elevar Therapeutics
26-May-2022 UCB Announces First Detailed Data from Two Phase 3 Bimekizumab Studies in Psoriatic Arthritis to be Presented at EULAR 2022 UCB
26-May-2022 AlzeCure gets approval to start Phase II clinical trial with non-opioid pain project ACD440 AlzeCure Pharma AB
25-May-2022 uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management uMotif
25-May-2022 PrecisionLife Wins Analytics Company of the Year at British Data Awards PrecisionLife
25-May-2022 Neonatal Diagnostics Company InfanDx AG Completes Two-Year Patient Follow-Up in BANON Study InfanDx AG
24-May-2022 First Presentations of Phase 3 Data for Bimekizumab Across the Full Spectrum of Axial Spondyloarthritis to be Shared at EULAR 2022 UCB
24-May-2022 Point of Care Diagnostic Market Worth $73,293 Million by 2031: Visiongain Research Inc Visiongain
23-May-2022 Global Vaccine Contract Manufacturing market is projected to grow at a CAGR of 11.18% By 2032: Visiongain Research Inc Visiongain